Hepatitis C Treatment Outcomes for People Who Inject Drugs Treated in an Accessible Care Program Located at a Syringe Service Program-Reference-Cited by-同舟云学术

Hepatitis C Treatment Outcomes for People Who Inject Drugs Treated in an Accessible Care Program Located at a Syringe Service Program

Published:2018-03-06 Issue:4 Volume:5 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Eckhardt Benjamin J¹²,Scherer Matthew³,Winkelstein Emily⁴,Marks Kristen²,Edlin Brian R⁴⁵

Affiliation:

1. Division of Infectious Diseases and Immunology, NYU School of Medicine, New York, New York

2. Division of Infectious Diseases, Weill Cornell Medicine, New York, New York

3. Division of Infectious Diseases, Columbia University Medical Center, New York, New York

4. National Development and Research Institutes New York, New York

5. Weill Cornell Medical College, New York, New York

Abstract

Abstract Hepatitis C virus (HCV) is a significant public health problem that disproportionately afflicts people who inject drugs. We describe outcomes of HCV treatment co-located within a syringe services program (SSP). Fifty-three participants started therapy, and 91% achieved sustained virologic response. SSPs provide an effective venue for HCV treatment.

Funder

National Institute on Drug Abuse

National Center for Advancing Translational Sciences

National Institutes of Health

Agency for Healthcare Research and Quality

Bristol-Myers Squibb

New York State AIDS Institute

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Link